The Dissolution Procedure: Development and …
The Dissolution Procedure: Development and Validation Based on: <1092> as published in Pharmacopoeial Forum, Vol. 31 (5), 2005 Dr. Elisabeth Krug Lilly Forschung GmbH Germany
Download The Dissolution Procedure: Development and …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ICH Topic Q 1 A Stability Testing Guidelines: …
www.pharma.gally.chCPMP/ICH/380/95 1/13 STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS ICH Harmonised Tripartite Guideline [EMEA Status as …
ICH Topic Q 3 A Impurities Testing Guideline: …
www.pharma.gally.chCPMP/ICH/142/95 1/11 IMPURITIES IN NEW DRUG SUBSTANCES ICH Harmonised Tripartite Guideline TABLE OF CONTENTS 1. Preamble 2 2. Classification of Impurities 2
ICH Topic Q 2 A Validation of Analytical Methods ...
www.pharma.gally.chCPMP/ICH/381/95 1/5 VALIDATION OF ANALYTICAL METHODS: DEFINITIONS AND TERMINOLOGY ICH Harmonised Tripartite Guideline …
ICH Q9 QUALITY RISK MANAGEMENT Quality Risk …
www.pharma.gally.chContent prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT
5.10. CONTROL OF IMPURITIES IN SUBSTANCES …
www.pharma.gally.ch5.10. Impurities in substances for pharmaceutical use EUROPEAN PHARMACOPOEIA 5.0 It should be noted that specific thresholds are applied to substances exclusively for veterinary use.
Related documents
Guideline on quality of oral modified release …
www.ema.europa.euThis guideline concerns quality aspects, especially pharmaceutical development and in vitro testing, of dosage forms in which the release of active substance is modified.
DECISION TREE #1: ESTABLISHING ACCEPTANCE …
www.ich.orgDECISION TREE #2: ESTABLISHING ACCEPTANCE CRITERION FOR A DEGRADATION PRODUCT IN A NEW DRUG PRODUCT Does degradation occur during product manufacture?
The Development and Validation of a Dissolution …
www.dissolutiontech.com16 Dissolution Technologies| AUGUST 2004 The Development and Validation of a Dissolution Method for Clomipramine Solid Dosage Forms Mehdi Ansari 1,3, Maryam Kazemipour 2, Javad Talebnia 1 email: mansari1345@yahoo.com
Toward Biorelevant Dissolution: Application of a …
www.dissolutiontech.comDissolution Technologies | FEBRUARY 2012 25 e-mail: james_mann@merck.com Toward Biorelevant Dissolution: Application of a Biphasic Dissolution Model as a Discriminating Tool for HPMC Matrices
Guideline on quality of oral modified release products
www.ema.europa.euGuideline on quality of oral modified release products EMA/492713/2012 Page 4/16 . 72 . Pharmaceutical development should establish the link …